Articles
Phylogica enhances peptide screening capabilities
Phylogica (ASX:PYC) has improved its Phylomer peptide screening platform to allow it to discover candidates that can penetrate cell walls and deliver drug cargoes to a specific target. [ + ]
Global Medisafe makes it to market
Global Medisafe Holdings has launched its first Clik-Lok safety syringe product in Europe and will soon start the process of securing Australian approval. [ + ]
Biomolecular in the bush - towards antibacterials without resistance
The RACI Division of Biomolecular Chemistry will hold its 2013 conference in the Blue Mountains in July. With themes of medicinal chemistry, chemical biology and drug discovery, here is a taste of what the meeting has in store. [ + ]
Prima to trial CVac in three more cancer types
Prima BioMed (ASX:PRR) has announced phase II trials for cancer treatment candidate CVac in pancreatic, colorectal and breast cancers. [ + ]
Microfluidic chip can help identify unwanted particles in water and food
A new process for making a three-dimensional microstructure that can be used in the analysis of cells could prove useful in counterterrorism measures and in water and food safety concerns. [ + ]
The green energy lab of the future
When Curtin University’s renewable energy research centre CRESTA closed in 2004, the university found itself lacking a facility devoted to renewable energy. So when Dr Sumedha Rajakaruna was asked to design and build a new lab, he made sure the full use of expensive renewable energy sources could be achieved. [ + ]
New technique reveals protein function
A new experimental technique allows users to study the function of individual proteins in individual cell types in a living organism. [ + ]
GI Dynamics gets funding for French obesity trial
The French Government has agreed to fund a two-year economic impact study of GI Dynamics’ (ASX:GID) EndoBarrier Therapy in obesity and type 2 diabetes. [ + ]
US patent verdict “troubling”: BIO
The head of US biotech industry group BIO has argued that the recent Supreme Court verdict on DNA patents could cause problems but he welcomed the ruling that the restrictions do not apply to composite DNA (cDNA) that is distinguishable from naturally occurring sequences. [ + ]
Tour of microbes - lessons not learned from history
The emergence of extensively drug-resistant tuberculosis on the border of North Queensland is raising concerns about this becoming a public health disaster in Australia. [ + ]
Why water quality tests don’t always accurately capture health risks
A toxin dangerous to humans may help E. coli fend off aquatic predators, enabling strains of E. coli that produce the toxin to survive longer in lake water than benign counterparts, a new study has found. [ + ]
The body electric: researchers move closer to low-cost, implantable electronics
New technology is paving the way for low-cost electronic devices that work in direct contact with living tissue inside the body. [ + ]
Why was there a sudden drop in the incidence of leprosy at the end of the Middle Ages?
Scientists have reconstructed the genome of medieval strains of the pathogen responsible for leprosy by exhuming centuries-old human graves to investigate why the incidence of leprosy decreased after the Middle Ages. [ + ]
Patrys’s antibody written up in melanoma journal
An article summarising the early-stage development of Patrys’s PAT-SM6 as a melanoma treatment has been published in Melanoma Research. [ + ]
Tour of microbes - eating organochlorides
Optimising growth conditions and matchmaking bacteria is all in a day’s work when bioremediating contaminated sites. [ + ]
